Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | LSS | P48449 | 4/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.42 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.41 |
| ▸ | PTGFR | P43088 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24258335 | 0.98 | MAOB (0.50) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9192348 | 0.90 | MAOB (0.45) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL7766286 | 0.90 | MAOB (0.45) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9192351 | 0.90 | MAOB (0.45) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9398346 | 0.86 | HDAC1 (0.43) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9191041 | 0.86 | HDAC1 (0.43) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9191043 | 0.86 | HDAC1 (0.43) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9398343 | 0.86 | MAOB (0.42) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9193081 | 0.86 | MAOB (0.42) | MAOBTAAR1HDAC1HDAC8GAA | |
| SCHEMBL9193072 | 0.86 | MAOB (0.42) | MAOBTAAR1HDAC1HDAC8GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3177612-B1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION AS (DK) | 2022-02-23 | — | — | EP | disclosed |